February 29th 2024
Susan C. Modesitt, MD, FACOG, FACS, discusses the role of PARP inhibitors in the treatment of patients with ovarian cancer.
January 31st 2018
Emerging data have confirmed that ovarian cancer is a much more heterogeneous disease than previously recognized.